Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis

Journal of Clinical Rheumatology

Volumn 19, Issue 7, 2013, Pages 386-389

  Adamson, Rosemary ^a   Yazici, Yusuf ^b   Katz, Edward S ^b   Greisman, Stewart G ^c   Steiger, David ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

adverse effect; hypersensitivity; myocarditis; TNF antagonist

Indexed keywords

ADALIMUMAB; CYCLOPHOSPHAMIDE; ETANERCEPT; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; VANCOMYCIN;

ADULT; ARTHRITIS; ARTICLE; AUTOPSY; CARDIOGENIC SHOCK; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG ERUPTION; DRUG WITHDRAWAL; EMERGENCY WARD; FEMALE; HEART ARREST; HEART FAILURE; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MYOCARDITIS; NAUSEA; NECROTIZING EOSINOPHILIC MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RELAPSING POLYCHONDRITIS; TRANSTHORACIC ECHOCARDIOGRAPHY; VOMITING;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; AUTOPSY; COMORBIDITY; EOSINOPHILIA; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; POLYCHONDRITIS, RELAPSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885187237     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3182a701cb     Document Type: Article

References (23)

1. Burmester GR, Panaccione R, Gordon KB, et al. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis and Crohn's disease. Ann Rheum Dis. 2013;72:517-524.
2. Paulo C, Benucci M, Manfredi M, et al. Hypersensitivity reactions to biologic agents with special emphasis on tumor necrosis factor-> antagonists Curr Opin Allergy Clin Immunol. 2007;7:393-403.
3. Slattery E, Ismail N, Sheridan J, et al. Myocarditis associated with infliximab\: A case report and review of the literature. Inflamm Bowel Dis. 2011;17:1633-1634.
4. Herzog CA, Snover DC, Staley NA. Acute necrotizing eosinophilic myocarditis Br Heart J. 1984;52:343-348.
5. Parrillo JE. Heart disease and the eosinophil. N Engl J Med. 1990; 323:1560-1561.
6. Getz MA, Subramaniam R, Logemann T, et al. Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis. Ann Intern Med. 1991;115:201-202.
7. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343: 1388-1398.
8. Knockaert DC. Cardiac involvement is systemic inflammatory diseases. Eur Heart J. 2007;28:1797-1804.
9. Del Russo, Petix NR, Pratesi M, et al. Cardiovascular involvement in relapsing polychondritis. Semin Arthritis Rheum. 1997;26:840-844.
10. Cooper LT, Berry GJ, Shabetai R. Idiopathic giant cell myocarditisVnatural history and treatment. N Engl J Med. 1997;336:1860-1866.
11. Spry CJ, Take M, Tai PC. Eosinophilic disorders of the myocardium and endocardium. Heart Vessels. 1985;1:s240-s242.
12. Sabatine MS, Poh KK, Mega JL, et al. Case 36-2007\: A 31-year old woman with rash, fever, and hypotension. N Engl J Med. 2007;357: 2167-2178.
13. Hoit BD, Gupta S. Restrictive, obliterative, and infiltrative cardiomyopathies. In: Fuster V, O'Rourke RA, Walsh RA, et al, eds. Hurst'. The Heart. 12th ed. New York, NY: McGraw Hill Medical; 2008:851-862.
14. Fenoglio JJ, McAllister HA, Mullick FG. Drug related myocarditis. Hum Pathol. 1981;12:900-907.
15. Burke AP, Saenger J, Mullick F, et al. Hypersensitivity myocarditis. Arch Pathol Lab Med. 1991;115:764-769.
16. Taliercio CP, Olney BA, Lie JT. Myocarditis related to drug hypersensitivity. Mayo Clin Proc. 1985;60:463-468.
17. Ben m'rad M, Leclerc-Mercier S, Blanche P, et al. Drug-induced hypersensitivity syndrome. Clinical and biological disease patterns in 24 patients. Medicine. 2009;88:131-140.
18. Galiuto L, Enriquez-Sarano M, Reeder GS, et al. Eosinophilic myocarditis manifesting as myocardial infarction; early diagnosis and successful treatment. Mayo Clin Proc. 1997;72:603-610.
19. Kazama R, Okura Y, Hoyano M, et al. Therapeutic role of pericardiocentesis for acute necrotizing eosinophilic myocarditis with cardiac tamponade. Mayo Clin Proc. 2003;78:901-907.
20. DeMello DE, Liapis H, Jureidini S, et al. Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med. 1990;323:1542-1545.
21. Cooper LT, Zehr KJ. Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis. Nat Clin Pract Cardiovasc Med. 2005;2:544-548.
22. Al Ali AM, Straatman LP, Allard MF, et al. Eosinophilic myocarditis: case series and review of the literature. Can J Cardiol. 2006;22: 1233-1237.
23. Kwon HJ, Cote TR, Cuffe MS, et al. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med. 2003;138:807-811.